This Solicitation opportunity from Department Of Defense was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BUPROPION HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Bupropion Hydrochloride Sustained Release Tablets, 150 mg, in units of 60 tablets per bottle, under NSN 6505014983167. All product specifications must comply with the DLA Master List of Technical and Quality Requirements, including Medical Marking Standard No. 1A dated February 4, 2013, which supersedes MIL-STD-129. Labeling must include the NSN, manufacturer name, CAGE code, date of manufacture, expiration date, contract number, and lot number. The product must be stored at room temperature between 59°F and 86°F (15°C to 30°C), kept dry and protected from light. A shelf life of 36 months, non-extendable, is mandated for this Type I (Code Q) item. Packaging must conform to commercial standards and be designed to protect contents from damage during transit, with exterior shipping containers suitable for safe delivery via common carrier at the lowest possible rate. The drug is regulated by the FDA, requiring contracting officials to submit a referral in EBS with bidder and manufacturer details for confirmation. No mercury or mercury-containing compounds may be intentionally added or come into direct contact with the product, except for functional uses in batteries, fluorescent lights, sensors, or specified chemical reagents, with portable devices containing mercury requiring shockproof construction and secondary containment per NAVSEA 5100-003D. Delivery is required FOB destination within 20 days, with zero variance allowed in quantity. Acceptance and inspection occur at the destination, and the item is to be delivered to Fort Stewart, Georgia. Approved manufacturers include GlaxoWellcome Inc dba AmerisourceBergen, Cardinal Health, ScieGen Pharmaceuticals, and Radha Pharmaceuticals, each with specific NDC numbers listed.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
BUPROPION HCL SUSTAINED RELEASE TABLETS
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
150 MG., 60'S. UNIT OF ISSUE BOTTLE .. LABELING AND MARKING MUST IN
ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013.
1 BT = 60 TT
LABELS SHALL INCLUDE: NSN MANUFACTURER AND CAGE DATE OF MANUFACTURE,
EXPIRATION OR RETEST DATE CONTRACT NUMBER/LOT NUMBER. STORE AT ROOM
TEMPERATURE BETWEEN 59OF AND 86OF (15OCTO 30OC). KEEP DRY AND OUT OF
LIGHT.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3269
SECTION B
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
NSN 6505014983167 1/28/16
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
GLAXO WELLCOME INC DBA 34006 P/N NDC00173-0135-55 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00173-0135-55 CARDINAL HEALTH, INC. 00E55 P/N NDC00185-0415-60 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00185-0415-60 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00591-3541-60 SCIEGEN PHARMACEUTICALS INC 8NLP1 P/N NDC50228-0175-60 RADHA PHARMACEUTICALS INC 8PNH3 P/N NDC77771-0175-60
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015009365 0001 BT 1.000
NSN/MATERIAL:6505014983167
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-498-3167 Quantity: 1 BT Purchase Request: 7015009365QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS